Abstract
Despite experiencing similar benefits from treatment, Black patients aged 60 years and younger with acute myeloid leukemia have worse survival outcomes than White patients. Results from a new SEER and CALGB/Alliance database analysis point to the complexity of racial disparities in cancer care.